Detalhe da pesquisa
1.
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Blood
; 141(25): 3031-3038, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084383
2.
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Blood
; 142(23): 1960-1971, 2023 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647654
3.
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10388): 1571-1583, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116523
4.
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
Blood
; 139(23): 3366-3375, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081255
5.
The clinical impact of the molecular landscape of acute myeloid leukemia.
Haematologica
; 108(2): 308-320, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722402
6.
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
Haematologica
; 108(3): 705-716, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226495
7.
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine.
Haematologica
; 108(7): 1886-1899, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519323
8.
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.
Haematologica
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058184
9.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678031
10.
An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape.
Curr Oncol Rep
; 25(4): 369-378, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808557
11.
Updates on targeted therapies for acute myeloid leukaemia.
Br J Haematol
; 196(2): 316-328, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34350585
12.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665578
13.
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.
Haematologica
; 107(9): 2064-2071, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142153
14.
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
Haematologica
; 107(4): 836-843, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348451
15.
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
J Oncol Pharm Pract
; 28(6): 1340-1349, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134554
16.
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Br J Haematol
; 192(5): 832-842, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529373
17.
Potential targeting of FLT3 acute myeloid leukemia.
Haematologica
; 106(3): 671-681, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703795
18.
A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia.
Haematologica
; 106(4): 1022-1033, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504139
19.
A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
Haematologica
; 106(8): 2121-2130, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853292
20.
Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia.
Am J Hematol
; 96(6): 735-746, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625753